Hepatic encephalopathy (HE) is a disorder that occurs due to liver dysfunction, leading to the accumulation of toxins in the blood that affects brain function. The disease is characterized by a wide range of neurological symptoms that can vary from mild confusion to coma. The Hepatic Encephalopathy Market is expected to witness significant growth in the coming years due to several factors. One of the key drivers of the market growth is the increasing prevalence of liver diseases. According to the World Health Organization (WHO), liver diseases are responsible for over 1.3 million deaths globally each year. The most common causes of liver diseases include viral hepatitis, alcohol-related liver disease, non-alcoholic fatty liver disease, and autoimmune hepatitis. As the incidence of liver diseases continues to rise, the demand for effective treatments for hepatic encephalopathy is also expected to increase, driving the growth of the market.
Read more @ https://creativeedge16.blogspot.com/2023/04/hepatic-encephalopathy-market.html
